Locations:
Search IconSearch

Diabetes & Endocrinology

19-EMI-1348-WL-Calculator-CQD

Prediction Model Estimates Anticipated Weight Loss from Four Common Anti-Obesity Medications

Shared decision-making tool published in a recent study fills void

19-END-1288-Testosterone-CQD

Testosterone Replacement Therapy Does Not Increase or Decrease Cardiovascular Risk, Study Finds

Risks and rewards of supplementation must be carefully weighed for older men with secondary hypogonadism

Bariatric surgery

How to Treat Severe Obesity as a Chronic Disease

7 tips for better, multidisciplinary obesity care

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-END-1083-Cangliflozin-CQD

After Metabolic Surgery, Canagliflozin Reduces BMI and Blood Glucose Levels in Patients with Type 2 Diabetes

New study finds that the average patient can expect to lose an additional 3.5kg on canagliflozin

19-EMI-1203-Vitamin-D3-CQD

Vitamin D3 Supplementation Fails to Significantly Lower Diabetes Risk in Patients with Pre-diabetes

Study confirms gold standards of weight loss, nutrition and exercise for diabetes prevention

palpating-neck_650x450

Individualized Management of Subclinical Hypothyroidism

What to consider when weighing options for treatment

thyroid_650x450

Aggressive Screening and Treatment for Subclinical Hypothyroidism: Benefits vs Risks

Screening guidelines differ for thyroid disease in the general population

Human thyroid gland. Xray image. 3D illustration.

Identifying Subclinical Hypothyroidism

What causes elevated TSH levels and when should we consider treating subclinical hypothroidism?

BackPage 10 of 16Next

Advertisement

Ad